Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional Results available

Study Evaluating The Safety Of AAB-003 (PF-05236812) In Subjects With Alzheimer's Disease

ClinicalTrials.gov ID: NCT01193608

Public ClinicalTrials.gov record NCT01193608. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 7:49 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1, Multicenter, Randomized, Double-blind, Placebo-controlled, Adaptive, Multiple Ascending Dose Study Of The Safety, Tolerability And Pharmacokinetics Of Aab-003 (Pf-05236812) In Subjects With Mild To Moderate Alzheimer's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a study to evaluate the safety of multiple doses of AAB-003 (PF-05236812) in patients with mild to moderate Alzheimer's Disease. Patients will receive either AAB-003 (PF-05236812) or placebo. Each patient's participation will last approximately 41 weeks.

Study identification

NCT ID
NCT01193608
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Pfizer
Industry
Enrollment
88 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
50 Years to 89 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2010 (Type not available)
Primary completion
Oct 2013 (Actual)
Completion
Oct 2013 (Actual)
Last update posted
Feb 23, 2017

2010 – 2013

United States locations

U.S. sites
23
U.S. states
9
U.S. cities
14
Facility City State ZIP Site status
Early Phase Investigational Center Escondido California 92025 —
Synergy Clinical Research Center of Escondido Escondido California 92025 —
MD Clinical Hallandale Florida 33009 —
Franck's Pharmacy Ocala Florida 34471 —
Munroe Regional Medical Center Ocala Florida 34471 —
Renstar Medical Research Ocala Florida 34471 —
Advanced Imaging of Ocala Ocala Florida 34481 —
Atlanta Center for Medical Research Atlanta Georgia 30308 —
Foers Medical Arts Pharmacy Bethesda Maryland 20814 —
CBH Health, LLC Rockville Maryland 20850 —
Borgess Medical Center Kalamazoo Michigan 49048 —
Borgess Research Institute Kalamazoo Michigan 49048 —
KNI/Southwest Michigan Imaging Center, LLC Kalamazoo Michigan 49048 —
Brentwood Behavioral Healthcare Flowood Mississippi 39232 —
Marty's Pharmacy Flowood Mississippi 39232 —
Precise Research Centers Flowood Mississippi 39232 —
Millennium Psychiatric Associates, LLC Creve Coeur Missouri 63141 —
DePaul Health Center St Louis Missouri 63044 —
Memory Enhancement Center of America, Inc. Eatontown New Jersey 07724 —
Pharmacare USA Edison New Jersey 08837 —
Central Jersey Radiology Oakhurst New Jersey 07755 —
Belmont Center for Comprehensive Treatment Philadelphia Pennsylvania 19131-1689 —
Albert Einstein Medical Center Philadelphia Pennsylvania 19141 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01193608, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 23, 2017 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01193608 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →